dapi has been researched along with Cardiac Hypertrophy in 1 studies
DAPI: RN given refers to parent cpd.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Young, D | 1 |
| Maitra, RK | 1 |
| Gupta, A | 1 |
| Popovic, ZB | 1 |
| Yong, SL | 1 |
| Mahajan, A | 1 |
| Wang, Q | 1 |
| Sen, S | 1 |
1 other study available for dapi and Cardiac Hypertrophy
| Article | Year |
|---|---|
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.
Topics: Aging; Animals; Cardiomegaly; Disease Progression; Female; Fluorescein-5-isothiocyanate; Fluorescent | 2008 |